These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19730364)

  • 1. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy.
    Weaver DL; Le UP; Dupuis SL; Weaver KA; Harlow SP; Ashikaga T; Krag DN
    Am J Surg Pathol; 2009 Nov; 33(11):1583-9. PubMed ID: 19730364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
    Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
    Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.
    Takeshita T; Tsuda H; Moriya T; Yamasaki T; Asakawa H; Ueda S; Sato K; Aida S; Tamai S; Matsubara O; Hase K; Yamamoto J
    Ann Surg Oncol; 2012 Apr; 19(4):1160-6. PubMed ID: 21989659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel Node Biopsy Examination for Breast Cancer in a Routine Laboratory Practice: Results of a Pilot Study.
    Khoo JJ; Ng CS; Sabaratnam S; Arulanantham S
    Asian Pac J Cancer Prev; 2016; 17(3):1149-55. PubMed ID: 27039740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma.
    Liu LH; Siziopikou KP; Gabram S; McClatchey KD
    Arch Pathol Lab Med; 2000 Nov; 124(11):1670-3. PubMed ID: 11079022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer.
    Nährig J; Richter T; Kowolik J; Kuhn W; Avril N; Höfler H; Werner M
    Anticancer Res; 2000; 20(3B):2209-12. PubMed ID: 10928179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.
    Cote RJ; Peterson HF; Chaiwun B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Gusterson B; Neville AM
    Lancet; 1999 Sep; 354(9182):896-900. PubMed ID: 10489948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.
    Geertsema D; Gobardhan PD; Madsen EV; Albregts M; van Gorp J; de Hooge P; van Dalen T
    Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer.
    Leers MP; Schoffelen RH; Hoop JG; Theunissen PH; Oosterhuis JW; vd Bijl H; Rahmy A; Tan W; Nap M
    J Clin Pathol; 2002 May; 55(5):359-66. PubMed ID: 11986342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.
    Cserni G; Bianchi S; Vezzosi V; Peterse H; Sapino A; Arisio R; Reiner-Concin A; Regitnig P; Bellocq JP; Marin C; Bori R; Penuela JM; Iturriagagoitia AC
    J Clin Pathol; 2006 May; 59(5):518-22. PubMed ID: 16497870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
    Weaver DL; Krag DN; Ashikaga T; Harlow SP; O'Connell M
    Cancer; 2000 Mar; 88(5):1099-107. PubMed ID: 10699901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast Sentinel Lymph Node Frozen Section Practice: An Enterprise Audit as a Guide for Moving Forward.
    Czaja R; Wu R; Jorns JM
    Arch Pathol Lab Med; 2021 Aug; 145(8):1018-1024. PubMed ID: 33212474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.